Secondary Cachexia in Patients with Advanced Cancer (414-C)
نویسندگان
چکیده
منابع مشابه
Cachexia in patients with advanced cancer.
Cancer cachexia generally is considered to be the end stage in the progression of nutritional deterioration and wasting of malignancy (Ottery, 1995). In patients with advanced cancer, this condition is very common and decreases quality of life, as well as survival (Fearon et al., 2001; Ottery; Smith & Souba, 2001; Whitman, 2000). However, if early diagnosis and intervention can control cachexia...
متن کاملCachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
INTRODUCTION Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients. Cachexia index (CXI) was developed to assess the degree of cachexia in these patients. METHODS Patients with metastatic NSCLC diagnosed between January 1, 2000, and June 30, 2011, at our institution were retrospectively studied. Abdominal computed tomography scans done within 1 month of diagnosis w...
متن کاملCachexia in Cancer Patients
Cancer is a leading cause of death worldwide [1]. Besides, overall survival of cancer patients is negatively affected by the presence of comorbidities. In this context, more than one-half of all cancer patients suffer from cachexia. Cachexia is a debilitating condition with high incidence in cancer patients and may lead to delayed, missed, or decreased treatments [2]. Cancer cachexia (CC) has b...
متن کاملCentral tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
BACKGROUND Skeletal muscle wasting is considered the central feature of cachexia, but the potential for skeletal muscle anabolism in patients with advanced cancer is unproven. OBJECTIVE We investigated the clinical course of skeletal muscle wasting in advanced cancer and the window of possible muscle anabolism. DESIGN We conducted a quantitative analysis of computed tomography (CT) images f...
متن کاملHypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic
BACKGROUND Elevated resting energy expenditure (REE) may contribute to weight loss and symptom burden in cancer patients. AIMS The aim of this study was to compare the velocity of weight loss, symptom burden (fatigue, insomnia, anxiety, and anorexia-combined score as measured by the Edmonton Symptom Assessment Score), high-sensitivity C-reactive protein, and survival among cancer patients ref...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pain and Symptom Management
سال: 2011
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2010.10.116